Login
From:
Sleep Review
(Uncensored)
subscribe
Pivotal Phase 3 Topline Results for Neuromuscular-Targeting OSA Drug Candidate
https://sleepreviewmag.com/sleep-treatments/pharmaceuticals/emerging-compounds/pivotal-phase-3-topline-results-neuromuscular-targeting-osa-drug-candidate-apnimed/
links
backlinks
Tagged with:
osa
phase 3
apnimed
emerging compounds
A 12-month study evaluated the efficacy and safety of the drug candidate in adults with mild, moderate, and severe OSA.
Roast topics
Find topics
Find it!
